Physician
Shah, Binod
Shah, Binod was paid $1.76M by Medicaid between Jan 2018 and Nov 2024, across 36 billing codes. Its largest line is 97530, Therapeutic activities, direct patient contact, each 15 minutes — 13% of everything it billed.
33Billing provider infoSHAH, BINOD
YONKERS, NY 10701
YONKERS, NY 10701
33aNPI1346334604assigned 10/03/2006
33bProvider typePhysical Medicine & Rehabilitation Physician
28Total paid$1.76M
24GClaims64,967
24DCodes billed36
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Physical Medicine & Rehabilitation Physician providers in New York
Rank by total paid#12 of 465
Median peer was paid$12K
This provider vs. median143×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,357 | $131K | |
| 2019 | 2,671 | $95K | |
| 2020 | 4,093 | $153K | |
| 2021 | 19,114 | $487K | |
| 2022 | 21,512 | $470K | |
| 2023 | 5,983 | $191K | |
| 2024incomplete | 7,237 | $227K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 13% | 6,672 | 2,363 | $221K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 2,800 | 2,601 | $214K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 11% | 7,334 | 2,594 | $201K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 8.3% | 4,325 | 3,615 | $147K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.6% | 1,020 | 974 | $116K |
| 76942 | 6.2% | 1,070 | 998 | $109K | |
| 97799 | 5.4% | 1,925 | 647 | $95K | |
| 97032 | 4.5% | 6,212 | 2,300 | $79K | |
| 97035 | 4.4% | 6,194 | 2,311 | $78K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.5% | 1,741 | 1,675 | $62K |
| 97162 | 3.1% | 695 | 681 | $55K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 3.1% | 4,488 | 3,634 | $54K |
24 more codes
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3.0% | 2,293 | $52K |
| 99442 | 2.8% | 569 | $49K | |
| 20552 | 2.0% | 1,126 | $35K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 2,509 | $27K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 2,248 | $26K |
| 95886 | 1.2% | 143 | $21K | |
| 95913 | 1.1% | 83 | $20K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,670 | $17K |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | <1% | 30 | $14K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 87 | $12K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 94 | $10K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,642 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 141 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 101 | $5K |
| 99401 | <1% | 185 | $4K | |
| 99443 | <1% | 31 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 427 | $3K |
| 86318 | <1% | 491 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 82 | $2K |
| 97014 | <1% | 161 | $2K | |
| A4550 | Surgical trays | <1% | 12 | $1K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 41 | $1K |
| 99072 | <1% | 2,293 | $185.50 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 32 | $94.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.